The most pronounced clash in the European Parliament's health-focused session on February 2, 2026, occurred between Romana Jerković (S&D) and Jessica Polfjärd (EPP) regarding the draft EU Cardiovascular Diseases Strategy. Jerković pushed for a robust, prevention-driven approach featuring early detection, regulation of unhealthy environments, tackling social and gender inequalities, and dedicated funding for the Safe Hearts Plan. Polfjärd echoed support for prevention but emphasized preserving national competences and involving farmers and industry, warning against overly prescriptive EU-wide measures. Viktória Ferenc (PfE) also cautioned against one-size-fits-all policies, advocating better integration with related diabetes strategies. This divergence framed a broader debate balancing the expansion of EU-level regulatory powers versus the respect for national sovereignty and sectoral interests.
This debate unfolded in the European Parliament’s Committee on Public Health (SANT) meeting, integrating discussions on cancer policy, the Cyprus Council Presidency health priorities, and the first reading of the cardiovascular strategy report.
Concrete Proposals vs. General Assurances: Romana Jerković presented a comprehensive draft report with specific policy orientations aiming to increase EU oversight and new funding mechanisms targeted at preventing cardiovascular diseases and reducing inequalities. She advocated explicit regulation of unhealthy product environments, a clearly defined fiscal framework, and a focus on measurable health equity goals. In contrast, speakers like Polfjärd and Ferenc offered more cautious stands, calling for flexibility to accommodate national differences and warning against EU overreach. Their positions were less anchored in concrete numerical targets or binding deadlines and leaned towards declarative support for prevention with calls for engagement of industry stakeholders.
Jerković's approach entails increased EU regulatory intervention in public health, particularly targeting unhealthy dietary and environmental factors. This could significantly impact the food industry and agricultural sectors by introducing stricter controls and potentially higher operational costs, contrasting with more flexible national policies favored by Polfjärd and others. Consumers and civil society might benefit from stronger consumer protection and reduced health inequalities. Meanwhile, national authorities could face challenges balancing EU-driven mandates with local socio-economic realities. The medical and healthcare providers would likely play a crucial role in early detection and prevention efforts, anticipating reinforced roles under the Safe Hearts strategy funding.
Beyond cardiovascular health, the session tackled persistent inequalities in cancer prevention and treatment, emphasizing the urgency of addressing disparities among EU member states and socio-economic groups. Debate participants like Elisabetta Zanon (ECO) and Caroline Berchet (OECD) underscored the need for sustainable, ring-fenced funding in the next Multiannual Financial Framework (2028–2034) to maintain momentum against cancer, which some MEPs feared might be compromised amid competing health priorities.
The debate marks an initial step in shaping a cohesive EU-wide cardiovascular strategy, laying bare the tensions between deeper EU integration in health policymaking versus preserving member state discretion. The extended deadline for amendments until mid-February 2026 suggests ongoing negotiations will seek to reconcile these differing visions. The European Commission's engagement, through its Safe Hearts Plan and responses during the session, signals institutional support for enhanced EU coordination but within the constraints of member state competences.
In sum, the debates reflect broader struggles over the balance of EU regulatory authority in sensitive public health domains, with tangible implications for industries, national governments, and citizens across the bloc.